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Abstract
We report on a male patient born to 
healthy, first cousin, Moroccan parents. 
During the pregnancy growth retardation 
was observed. Birth weight, length, and 
OFC were all well below the 3rd centile. 
Facial anomalies, microphthalmia, cleft 
palate, small penis, and flexion con- 
tractures of large joints were noted. Ce­
rebral MRI showed dysmyelination. The 
clinical course was characterised by feed­
ing difficulties, growth failure, lack of de­
velopment, photosensitivity, and death at
7 months. The main differential diagnoses 
were COFS syndrome and early onset 
Cockayne syndrome (CS). UV exposure of 
cultured fibroblasts showed inhibition of 
nucleic acids synthesis. Further DNA re­
pair studies showed extreme cellular sensi­
tivity to UV and xeroderma pigm entosum  
(XP)-like defective nucleotide excision re­
pair (NER), which in combination with 
the clinical symptoms indicated the very 
rare XP-CS complex. Complementation  
analysis showed that the XPG gene is 
affected in this patient. In cases suspected 
of having COFS syndrome and early onset 
CS, extensive DNA repair studies are 
needed to reach the definitive diagnosis, 
thereby allowing reliable genetic coun­
selling and prenatal diagnosis.
{J Med Genet 1996;33:607-610)
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CS complex.
To date seven independent cases of the rare 
xeroderma pigmentosum (XP)-Cockayne syn­
drome (CS) complex have been reported. Two 
belong to the XP complementation group B, 
1-3 two to D,45 and three to group G .6 8 We 
report on a furdier case and stress the import­
ance of performing extensive D N A  repair stud­
ies in cases suspected of having COFS 
syndrome (MIM 214150) and early onset CS 
(MIM 216400) in order to reach a correct 
diagnosis, thereby allowing reliable genetic 
counselling and prenatal diagnosis.
Methods
CASE REPORT
The male proband is the third child of healthy, 
first cousin, Moroccan parents. The pregnancy 
was complicated by growth retardation and 
delivery was induced at 38 weeks5 gestation. 
Birth weight was 1770 g, length 40*5 cm, and 
OFC 31 cm (all <3rd centile). Apgar scores at 
one and five minutes were 9 and 10 respectively.
On examination facial anomalies were observed 
including small palpebral fissures, prominent 
nasal bridge, small mouth, posteriorly rotated 
ears, micrognathia, and cleft palate. He had 
flexion contractures of the large joints and 
clenched hands with overlapping of the second 
finger over the third and the fifth finger over 
the fourth. Micropenis and pigmented spots 
on die trunk and right leg were noted (fig 1). 
Feeding difficulties were present from birth, 
necessitating tube feeding and admission to 
hospital (except for about two weeks) until he 
died at die age of 7 months. The clinical course 
was further characterised by the development 
of hepatomegaly, growth failure, and an almost 
complete absence of motor and mental de­
velopment. Retrospectively, one event of sun 
exposure with a hypersensitive skin reaction 
was noted; no other skin changes were ob­
served. He reacted to sound, but not to light 
stimuli. At die age of 7 months his weight was 
4300 g, length 51 cm, and OFC 36 cm (all <3rd 
centile). Necropsy was not performed. Family 
history was not contributory.
Figure 1 Note the prominent nasal bridges posteriorly 
rotated ears, micrognathiaj clenched hands with 
overlapping fingers, micropenis, and pigmented spot on the 
trunk.
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Figure 2 (A) Kinetics of RNA synthesis after 4 Jim 2 of UV ligkt. (B) UV dose response of DNA synthesis rate at 16 
hours after irradiation. (C) Cell survival assay, (D) Unscheduled D N A synthesis (UDS), I f  not too small for drawings 
bars are indicated in the survival at mes to represent standard errors from duplicate dishes,
DNA REPAIR ASSAYS
RNA synthesis
C overslip cultures of fibroblasts were exposed 
to 4 J/m2 of 254 nm UV light and labelled for 
one hour with 3H-uridine at the indicated times 
after irradiation. Cultures were fixed and pro­
cessed for autoradiography. RNA synthesis 
rates were measured by counting grains over 
40 to 50 nuclei and expressed as percentages 
of unirradiated control cultures.
D N A synthesis
Fibroblast cultures were prelabelled with 14C- 
thymidine overnight, exposed to various doses 
of UV3 incubated for two hours with 3H-thy- 
midine at 16 hours after irradiation^ and har­
vested, The ratio of 3H to 14C radioactivities3 
assessed by scintillation countings was taken as
a measure of the rate of DNA replication and 
expressed as a percentage of the ratio in un­
irradiated cells.
Cellular sensitivity
Sparsely seeded petri dish cultures were ex­
posed to UV and allowed to grow for another 
four to five days. Then the number of pro­
liferating cells in each dish was estimated by 
scintillation counting of the radioactivity in­
corporated during a two to three hour pulse 
labelling with 3H-thymidine. Cell survival was 
expressed as the ratio of irradiated over un­
irradiated cells. The results of this simplified 
UV survival assay fully agree with those ob­
tained in the more standard clonogenic assays 
(Jaspers and Raams3 unpublished data).
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Unscheduled DNA synthesis 
Coverslip cultures of fibroblasts were exposed 
to 10 J/m2 of254 nm UV light and subsequently 
labelled for two hours with 3H-thymidine. After 
fixation and processing for autora di ography, 
grains were counted above the nuclei of 50 
non-S-phase cells, as described in detail 
previously.47
Complementation analysis 
After preloading the cytoplasm with plastic 
microspheres of different sizes, two cell strains 
were fused using Sendai virus, seeded on cover­
slip s3 and assayed for unscheduled DNA syn­
thesis one day later. Grains were counted above 
5 0 nuclei in homodikaryons and hetero- 
dikaryons, discriminated by their content of 
cytoplasmic beads, as described in detail pre­
viously. 7
Results
G banded chromosomes of peripheral lym­
phocytes were normal. Cardiac and abdominal 
ultrasound showed no abnormalities. Ra­
diology of the skeleton was normal. Cerebral 
CT scan showed enlarged ventricles and ce­
rebral MRI dysmyelination and cerebellar 
hypoplasia; calcifications were not seen. On 
repeat ophthalmological examination micro­
phthalmia was seen, but no cataract or re­
tinopathy, Cortical blindness was suspected. 
Because early onset CS was in the differential 
diagnosis, DNA repair studies were initiated. 
Inhibition of nucleic acid synthesis after UV 
exposure is the usual parameter tested in cases 
of CS. During the first nine hours after UV 
irradiation, the patient’s cultured fibroblasts 
completely failed to recover their rate of RNA 
synthesis, under conditions where normal con­
trol cells returned to normal levels (fig 2A). 
Consistent with this result, DNA replication, 
measured at 16 hours after exposure to graded 
UV doses, was abnormally depressed as well 
(fig 2B). A cell survival assay confirmed UV 
hypersensitivity, which was more severe than 
usually observed in CS patients5 cells (fig 2C). 
As the failure to restore RNA and DNA syn­
thesis after UV irradiation* as well as the de­
creased cell survival, is not only associated with 
CS but also with XP (and XP-CS complex), 
DNA repair characteristics were studied fur­
ther. UV induced unscheduled DNA synthesis 
(UDS), measured by autoradiography, was less 
than 4% of that in normal cells (fig 2D), in­
dicating a strongly impaired overall NER, 
which is characteristic of XP but not of CS. 
For further genetic characterisation, the 
patient5s cells were fused to representatives 
from various XP complementation groups. In 
the heterokaryons, UDS was restored to normal 
levels after fusion with cells from XP groups B 
and D (compare to fig 2D), but not with 
group G cells (table). This result shows the 
involvement of the XPG (ERCC5) gene, which
is believed to specify the 3' strand incision
function in the NER process.9
Complementation analysis of defective N E R
Fusion with 
cell strain
Grains per nucleus: mean (SEM)
Homodikaryons Hcterodikaiyons
Patient Pa rtner
XPCS1BA (XP-B) 
XP6BH (XP-D) 
XP3BR (XP-G)
2-2 (0-2) 
2-5 (0*3) 
2*5 (0-3)
7-0 (0*6) 
13-0 (0-8) 
3-5 (0-4)
58-7 (2-3) 
65-6 (2-3) 
3*6 (0-3)
Discussion
There is considerable clinical overlap between 
early onset CS and COFS syndrome and 
Lowry10 and Patton et alu have previously poin­
ted to their close similarity. The sibs which 
Lowry et al12 described as a new syndrome were 
classified by some1113 as an example of early 
onset CS and by others1415 as an example of 
COFS syndrome. Because of the absence of 
cerebral calcifications, cataract, and re­
tinopathy, our initial diagnosis was COFS syn­
drome with early onset CS as a differential 
diagnosis. Detailed analysis of DNA repair 
showed the final (genetic) diagnosis to be XP- 
G. This underlines the importance of extensive 
DNA repair studies in cases suspected of having 
early onset CS and COFS syndrome in order 
to reach a correct diagnosis. XP and CS both 
feature skin hypersensivity to sunlight and be­
long to the nucleotide excision repair (NER) 
syndromes. Characteristically, CS has a defect 
in transcription coupled NER, whereas most 
XP groups are affected in both transcription 
coupled and “global55 N ER.16 Our case is the 
ninth patient with symptoms of CS belonging 
to an XP complementation group. Robbins17 
proposed that this XP/CS combination was a 
distinct clinical entity and called it “XP-CS 
complex”. The five patients from the four kind­
reds within complementation groups B and D  
have a combination of features of both X P and 
CS, whereas three others belonging to XP-G 
have virtually only CS. Our patient did not 
show overt XP symptoms. However, it is quite 
possible that his early demise and stay in hos­
pital for almost 7 months may have prevented 
the development of XP skin manifestations, like 
atrophic skin with hyper- and hypopigmented 
spots in sun exposed areas. Our report concerns 
the eighth patient with NER deficiency be­
longing to XP group G. In 1993 Vermeulen 
et al1 reviewed seven cases, including those 
described earlier as cases with severe early in­
fantile CS.6 Clinical variability within XP-G 
ranges from classical XP to early onset CS. 
Recently, Nouspikel and Clarkson18 detected 
point mutations in the XPG (ERCC5) genes 
of one XP-G patient with a mild XP pheno type. 
Mutational analysis in the other seven XP-G 
cases may indicate whether there is a pre­
dictable genotype-phenotype correlation. This 
analysis is currently under way in our patient 
and other patients with the XP-CS phenotype8 
(S G Clarkson, personal communication).
Based on the finding that the XPB and XPD 
gene products are part of the basal transcription 
factor TFIIH, it has been hypothesised that 
many of the symptoms of the XP-CS complex 
are caused by subtle deficiencies in basal tran­
scription.16 In this hypothesis, the clinical vari-
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ability within XP-G suggests that the XPG 
protein has some relation to basal transcription 
as well; however, direct enzymological support 
of this notion could not be obtained so far 
and has to await the development of more 
sophisticated in vitro repair/transcription as­
says. In conclusion, we report on a patient 
with developmental defects and failure to thrive 
suggestive of COFS syndrome or early onset 
CS, where cellular studies indicate a defect in 
the XP-G gene. We stress the importance of 
performing extensive DNA repair in cases sus­
pected of having COFS syndrome and early 
onset CS.
Most of the DNA repair studies were supported by the CEC 
Concerted Action Programme on DNA Repair.
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